Efficacy of LCS compared with manual techniques


Cost remains a large disadvantage to femtosecond laser cataract surgery

Femtosecond laser technology

The advancement in Femtosecond lasers has been remarkable, though debate continues about whether to become involved with the technology based on clinical efficacy and safety. The Catalys laser (Optimedica, Sunnyvale, California, USA) that our practice acquired in April 2012 has since had multiple upgrades - in particular improving power efficiency and accuracy. The most recent upgrade has reduced anterior capsulotomy time to less than 2 seconds, provided corneal incisions and dramatically reduced lens fragmentation times as well as enhancing the treatment zone. These improvements highlight that this technology has not yet reached maturity.

Another safety feature of the platform is the liquid optics interface, which causes only a small and transient rise in IOP.1 This is important for our elderly cataract patients who have significant co-morbidities such as glaucoma.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.